Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT02350634
Eligibility Criteria:
Inclusion Criteria:
* Projected life expectancy ≤ 6 months
Exclusion Criteria:
* Primary brain tumor, known metastases to the brain, central nervous system lymphoma
* Major, focal structural brain lesion
* Aggressively being treated with life sustaining measures
* Clinically significant infectious disease
* History of risk factors for Torsades de Pointes or are currently taking medication known to cause QT prolongation
* Have received or participated in a trial with investigational medications in the past 30 days
* Females of childbearing potential who are pregnant or not using adequate contraception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Maximum Age:
89 Years
Study:
NCT02350634
Study Brief:
Protocol Section:
NCT02350634